Clinical trial · Interventional
Enhanced Recovery Program After Laparoscopic Colon Cancer Surgery
Implementation of an Enhanced Recovery Program After Laparoscopic Colon Cancer Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
An enhanced recovery program has been developed to provide for colon cancer patients faster and more personalized postoperative treatment. Most of the previous studies have showed that the efficacy of the enhanced recovery program on both subjective and objective physical recovery of patients. However, such studies are rarely conducted in South Korea. The purpose of this study is to evaluate the feasibility and efficacy of a postoperative enhanced recovery program in patients who underwent laparoscopic colon cancer surgery at a tertiary hospital in Korea.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Enhanced recovery program | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- ERAS group
- description
- early recovery program with no preoperative mechanical bowel preparation, early diet initiation, and prevention of postoperative ileus after elective laparoscopic colon cancer surgery
- interventionNames
- Other: Enhanced recovery program
- type
- NO_INTERVENTION
- label
- Congrol group
- description
- Traditional, conventional perioperative treatment
Primary outcomes (2)
- measure
- Length of hospital stay
- timeFrame
- 30 days post-operatively
- description
- Duration of hospital stay from the date of operation to the date when a patient meets the following "discharge criteria". Discharge criteria: * Tolerance of consecutive 3 soft diet * Recovery of bowel function (without PONV) * No necessity of intravenous analgesics * Stable vital sign (afebrile)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Eligibility rule of enrollment * ECOG 0-2 * Pathologically diagnosed colon cancer * Stage I-III * No functional disturbance in liver, kidney, bone marrow * Informed consent Exclusion Criteria: * Emergent operation * Obstructive or perforated cancer * Rectosigmoid or rectal cancer * Synchronous tumor * Uncontrolled psychiatric or neurologic problems * Severe hepatic dysfunction (GOT, GPT ≥100IU/L) * Renal dysfunction (Cr ≥2mg/dl) * Recent MI, CVA, nitrate medication
References
Publications (0)
Data not yet available